Survey Suggests LGBTQI+ Latinx Community Not Receiving Tailored Cancer-related Information and Health Care
SAN FRANCISCO – Most LGBTQI+ Latinx have been afraid to share their gender identity and/or sexual orientation with a...
Search/Filter
Loading...
Poor and Minority Patients are More Likely to Have Cancer Detected via Emergency Room Visit
SAN FRANCISCO – Medicare patients from lower socioeconomic groups and several ethnic minority groups were more likely than their...
Culturally Tailored Intervention Enabled Low-income Asian American Women to Conduct HPV Self-sampling Test
SAN FRANCISCO – A culturally tailored intervention to improve human papillomavirus (HPV) screening among low-income Asian American women significantly...
Colorectal Cancer Mortality and Racial Disparity Varies Across U.S. Cities
SAN FRANCISCO – Racial disparities in death rates from colorectal cancer vary considerably across cities in the United States,...
Research Continues to Drive Advances Against Cancer
PHILADELPHIA — The American Association for Cancer Research (AACR) today released its annual Cancer Progress Report highlighting how research largely...
The AACR Applauds the Administration for its Plan to Protect the Public from the Dangers of E-cigarettes
AACR urges tighter regulation and increased funding for research into potential risks The American Association for Cancer Research (AACR)...
Patients With Metastatic Colorectal Cancer Harboring Certain BRAF Mutations May Respond to Anti-EGFR Therapy
PHILADELPHIA – Patients with metastatic colorectal cancer harboring a subset of non-V600 mutations in the BRAF gene, known as...
AACR Honors Steven R. Patierno with AACR Distinguished Lectureship on the Science of Cancer Health Disparities
PHILADELPHIA: – The American Association for Cancer Research (AACR) has announced Steven R. Patierno, PhD, as the recipient of...
A Liquid Biopsy Test Can Identify Patients Who May Respond to Immune Checkpoint Blockade
Test employs error correction to increase accuracy PHILADELPHIA – A new liquid biopsy test could detect microsatellite instability (MSI)...
Combinatorial Therapy Shows Early Promise in Patients With Relapsed Small Cell Lung Cancer
PHILADELPHIA – The PARP inhibitor olaparib (Lynparza) in combination with the chemotherapeutic agent temozolomide (Temodar) showed clinical efficacy in...